The UK’s National Institute for Health and Care Excellence (Nice) has declined to recommend two new Alzheimer’s drugs for routine NHS use in England. While disappointing for some families affected by ...
UK reimbursement authority NICE has recommended that the NHS in England can use AstraZeneca's Imfinzi as the first ...
Two new drugs to treat Alzheimer’s disease have been rejected for NHS use in England and Wales because they are too expensive to justify their “relatively small” benefits. The guidance applies to ...
A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has ...
Health secretary’s ‘power grab’ to override Nice comes amid growing concern move may be illegal and benefit big pharma ...
Great Britain’s new coalition government, led by the Conservative Party, has confirmed plans to strip some authority from the National Institute for Health and Clinical Excellence. Under the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results